Bioclonetics Immunotherapeutics, Inc. — Form C/A (Regulation Crowdfunding)
Bioclonetics Immunotherapeutics, Inc. of HEATH, TX filed a Form C/A (Regulation Crowdfunding) with the SEC on 2018-08-28. Target raise $10K, up to $683K. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2018-08-28
- Form: C/A
- Accession: 0001665160-18-000859
- Target amount: $10K
- Maximum amount: $683K
- Security type: Other
- Securities offered: 10,000
- Price: $1.0000
- Deadline: 2018-11-02
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0001701251
- Website: www.bioclonetics.com
- Legal status: Corporation
- Organized in: TX
- Incorporated: 2009-12-24
- Address: 1756 BISON MEADOW LANE, HEATH, TX, 75032
- Employees: 4
Financials (as filed)
- Total assets (most recent): $184K
- Cash (most recent): $184K
- Net income (most recent): $-217K
- Net income (prior): $-96K
- Short-term debt: $45K
- Long-term debt: $387K
People (13)
| Name | Role | Location |
|---|
| Gaurav Chandra | Chief Operating Officer | HEATH, TX |
| Gaurav Chandra | Vice President Research and Development | HEATH, TX |
| Joseph P. Cotropia, M.D. | President/CSO | HEATH, TX |
| Paul D. Fellegy | CFO | HEATH, TX |
| Paul D. Fellegy | Chief Financial Officer | HEATH, TX |
| Paul D. Fellegy | Treasurer | HEATH, TX |
| Seth Sheiner | Vice President Business and Scientific Development | HEATH, TX |
| Charles Cotropia | CEO | HEATH, TX |
| Charles Cotropia | CEO/President | HEATH, TX |
| Joseph Cotropia | CSO | HEATH, TX |
| Joseph Cotropia | Founder/CSO | HEATH, TX |
| Charles S. Cotropia | CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer | HEATH, TX |
| Charles S. Cotropia | Vice President | HEATH, TX |
Reg CF filing history (15)
More